Actuated Medical
Private Company
Total funding raised: $1.7M
Overview
Actuated Medical is a pioneering medical device company developing a platform technology centered on engineered motion to improve neurological interventions. Its flagship NeuralGlider system uses micro-oscillations to insert brain implants and deliver biologics with greater precision and less tissue trauma, aiming to improve implant performance and therapeutic outcomes. Founded in 2008, the company is ISO 13485 certified, holds a significant intellectual property portfolio, and collaborates with leading academic and clinical partners. It operates as a preclinical-stage, revenue-generating entity, providing tools and expertise to researchers and therapy developers in the rapidly advancing field of brain health.
Technology Platform
Patented platform using controlled micro-oscillations (engineered motion) to improve precision and reduce tissue trauma during brain implant insertion and targeted biologics delivery. Commercialized as the NeuralGlider system.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Actuated Medical operates in the niche of precision brain access tools. Direct competitors may include other specialized research tool companies and in-house R&D teams at large neuromodulation companies (e.g., Medtronic, Boston Scientific, Abbott). Its competitive advantage lies in its patented, focused actuation technology, strong IP portfolio, and early-mover evidence generation in reducing tissue trauma during implantation.